Literature DB >> 18628287

Tolerability of methotrexate and leflunomide combination therapy for inflammatory arthritis in routine clinical practice: results of a four-centre study.

A Kaul, D T O'Reilly, R K Slack, D Collins, J Walmsley, O Duke, P D W Kiely.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18628287     DOI： 10.1093/rheumatology/ken240

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate.

Authors:  Grigorios T Sakellariou; Fares E Sayegh; Athanasios D Anastasilakis; George A Kapetanos
Journal:  Rheumatol Int       Date:  2012-11-05       Impact factor: 2.631

Review 2.  Perioperative management of immunosuppression in rheumatic diseases--what to do?

Authors:  Peter Härle; Rainer H Straub; Martin Fleck
Journal:  Rheumatol Int       Date:  2009-12-24       Impact factor: 2.631

Review 3.  Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery.

Authors:  Pamela T Wong; Seok Ki Choi
Journal:  Int J Mol Sci       Date:  2015-01-13       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.